Clinical Trials List
2022-04-01 - 2026-03-31
Phase III
Recruiting8
ICD-10C50.011
Malignant neoplasm of nipple and areola, right female breast
ICD-10C50.012
Malignant neoplasm of nipple and areola, left female breast
ICD-10C50.019
Malignant neoplasm of nipple and areola, unspecified female breast
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9174.0
Malignant neoplasm of female breast, nipple and areola
-
Trial Applicant
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- Yung-Chang Lin Division of Hematology & Oncology
- Chan-Keng Yang Division of Hematology & Oncology
- 周旭桓 Division of General Surgery
- 阮昱翔 Division of Radiology
- Wen-Ling Kuo Division of General Surgery
- Mengting Peng Division of Hematology & Oncology
- 沈士哲 Division of General Surgery
- Chi-Chang Yu Division of General Surgery
- Wen-Chi Shen Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Chun-Hui Lee Division of Hematology & Oncology
- Jui-Hung Tsai Division of Hematology & Oncology
- 楊舜如 Division of Hematology & Oncology
- Yao-Lung Kuo Division of General Surgery
- Kuo-Ting Lee Division of General Surgery
- Zhu-Jun Loh Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Yao-Chung Wu Division of General Surgery
- Chen-Teng Wu Division of General Surgery
- Liang-Chih Liu Division of General Surgery
- 黃至豪 Division of General Surgery
- Chih-Jung Chen Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 林燕淑 Division of General Surgery
- 賴亦貞 Division of General Surgery
- 許志堅 Division of Ophthalmology
- Yi-Fang Tsai Division of General Surgery
- Jiun-I Lai Division of General Surgery
- 郭懿萱 Division of Ophthalmology
- 邱仁輝 Division of General Surgery
- Chun-Yu Liu Division of Hematology & Oncology
- 陳彥蓁 Division of General Surgery
- 鄭涵方 Division of General Surgery
- Chi-Cheng Huang Division of General Surgery
- Ta-Chung Chao Division of Hematology & Oncology
- 馮晉榮 Division of General Surgery
- 陳柏方 Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- MING-YANG WANG Division of General Surgery
- 張端瑩 Division of Hematology & Oncology
- YEN-SHEN LU Division of Hematology & Oncology
- WEI-LI MA Division of Hematology & Oncology
- Wei-Wu Chen Division of Hematology & Oncology
- 林柏翰 Division of Hematology & Oncology
- 陳怡君 Division of Hematology & Oncology
- 林季宏 Division of Hematology & Oncology
- 郭文宏 Division of General Surgery
- 羅喬 Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Huey-En Tzeng Division of Hematology & Oncology
- HSIN-CHEN LIN Division of Hematology & Oncology
- 王國鐘 Division of General Surgery
- ZHENG-WEI ZHOU Division of Hematology & Oncology
- 楊陽生 Division of Hematology & Oncology
- I-Chen Tsai Division of General Surgery
- Kuan-Der Lee Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
25 participants
-
Global
1100 participants
